Task order 1 for access to outpatient prescription and patient level drug utilization data
Ended Awarded Last action
- Contract number
- 75F40120F19001
- Awardee
-
Source Healthcare Analytics LLC UEI DKDESVA1TRY7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $21,267,389
Award facts
- Contract value 100% obligated
- $21,267,389.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541519 Other Computer Related Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Penllyn, PA 19422, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$0 | |
| Other Administrative Action | $1,039,134 | |
| Exercise an Option | $4,208,422 | |
| Exercise an Option | $4,125,407 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $4,044,043 | |
| Exercise an Option | $3,964,283 | |
| Original award | $3,886,100 |
About this award
The U.S. Food and Drug Administration (FDA) awarded Source Healthcare Analytics LLC, a provider of outsourced development and data analytics services to the pharmaceutical and medical device industries, a firm fixed-price delivery order valued at $21.3 million. Issued on May 22, 2020, under a larger $45 million indefinite delivery contract, this task order provides the FDA access to outpatient prescription and patient-level drug utilization data to support the agency's drug safety monitoring efforts. The contract is performed in Penllyn, Pennsylvania, and includes no set-aside designation. The delivery order has a completion date of August 21, 2025, reflecting a five-year period of data access and analysis services.
This engagement supports the FDA's post-market surveillance activities by leveraging real-world prescription data to monitor drug safety and effectiveness across the U.S. healthcare system. Source Healthcare Analytics' expertise in pharmaceutical program development and data management, combined with access to comprehensive prescription utilization datasets, enables the FDA to conduct ongoing pharmacovigilance activities and respond to emerging safety signals more effectively. The contract represents a continuation of the vendor's established relationship with the FDA in providing critical healthcare data services for regulatory oversight purposes.
Quick answers
Who was awarded contract 75F40120F19001?
75F40120F19001 was awarded to Source Healthcare Analytics LLC by Food and Drug Administration (Department of Health and Human Services) on May 22, 2020.
How much is contract 75F40120F19001 worth?
The government has obligated $21,267,389 on 75F40120F19001.
Is contract 75F40120F19001 an order under another contract?
Yes. 75F40120F19001 is a delivery order under 75F40120D00012, an indefinite delivery contract.
Was contract 75F40120F19001 competed?
The extent of competition for 75F40120F19001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award